New Revelations Show Unusual Conditions At Now-Banned Sun India Plant
This article was originally published in PharmAsia News
Executive Summary
Newly reported information from a report shows an inspection by the U.S. FDA of a Sun Pharmaceutical Industries production plant in India did not find just run-of-the-mill violations, it found chaotic conditions.